Citations

Citations to this article as recorded by  

• PSP-Richardson syndrome mimics: An overview and pragmatic approach
  J. Necpál, M. Borsek, B. Jeleňová
  Revue Neurologique.2024; 180(1-2): 12.     CrossRef
• Concomitant Medications for Progressive Supranuclear Palsy
  Jay M. Iyer, Douglas Gunzler, Anthony E. Lang, Lawrence I. Golbe, Alexander Pantelyat, Adam L. Boxer, Anne-Marie Wills
  JAMA Neurology.2024; 81(3): 295.     CrossRef
• Existing statistical measures and techniques in detecting and evaluating progressive supranuclear palsy, its phenotypes by using MRI modalities: A Review
  Nirmal Adam Sait, J Kathirvelan
  Materials Today: Proceedings.2023; 80: 2000.     CrossRef
• The role of magnetic resonance imaging in the diff erential diagnosis of Parkinson’s disease
  A. A. Tappakhov, T. E. Popova
  Russian neurological journal.2023; 28(1): 5.     CrossRef
• Clinical features of progressive supranuclear palsy
  Yafei Wen, Qijie Yang, Bin Jiao, Weiwei Zhang, Jingyi Lin, Yuan Zhu, Qian Xu, Hui Zhou, Ling Weng, Xinxin Liao, Yafang Zhou, Junling Wang, Jifeng Guo, Xinxiang Yan, Hong Jiang, Beisha Tang, Lu Shen
  Frontiers in Aging Neuroscience.2023;[Epub]     CrossRef
• Mechanisms linking cerebrovascular dysfunction and tauopathy: Adding a layer of epiregulatory complexity
  Yoon A. Kim, Marian Mellen, Caghan Kizil, Ismael Santa‐Maria
  British Journal of Pharmacology.2023;[Epub]     CrossRef
• Midbrain area and the hummingbird sign from brain MRI in progressive supranuclear palsy and idiopathic normal pressure hydrocephalus
  Johan Virhammar, Harald Blohmé, Dag Nyholm, Charalampos Georgiopoulos, David Fällmar
  Journal of Neuroimaging.2022; 32(1): 90.     CrossRef
• Cognitive, Psychiatric, and Motor Symptoms–Based Algorithmic Approach to Differentiate Among Various Types of Dementia Syndromes
  Rehab Magdy, Mona Hussein
  Journal of Nervous & Mental Disease.2022; 210(2): 129.     CrossRef
• Idiopathic normal pressure hydrocephalus-like MRI features in patients with progressive supranuclear palsy: a comparative case-control study
  Halil Onder, Bilge Kocer, Selcuk Comoglu
  Neurological Research.2022; 44(9): 807.     CrossRef
• Targeting alpha-synuclein or tau for treating neurodegenerative movement disorders
  M. Lopez-Cuina, W.G. Meissner
  Revue Neurologique.2022; 178(5): 460.     CrossRef
• Clinical Aspects of the Differential Diagnosis of Parkinson’s Disease and Parkinsonism
  Hae-Won Shin, Sang-Wook Hong, Young Chul Youn
  Journal of Clinical Neurology.2022; 18(3): 259.     CrossRef
• Dopamine transporter imaging in progressive supranuclear palsy: Severe but nonspecific to subtypes
  Qi‐Si Chen, Xin‐Yi Li, Ling Li, Jia‐Ying Lu, Yi‐Min Sun, Feng‐Tao Liu, Chuan‐Tao Zuo, Jian Wang
  Acta Neurologica Scandinavica.2022; 146(3): 237.     CrossRef
• CSF tau microtubule-binding region identifies pathological changes in primary tauopathies
  Kanta Horie, Nicolas R. Barthélemy, Salvatore Spina, Lawren VandeVrede, Yingxin He, Ross W. Paterson, Brenton A. Wright, Gregory S. Day, Albert A. Davis, Celeste M. Karch, William W. Seeley, Richard J. Perrin, Rama K. Koppisetti, Faris Shaikh, Argentina L
  Nature Medicine.2022; 28(12): 2547.     CrossRef
• Role of Multivoxel MR Spectroscopy Progressive Supranuclear Palsy – A Preliminary Study
  Sandhya Mangalore, Manoj Kumar, Pramod Pal, Jitender Saini, Shaik Pasha, Ravi Yadav
  Neurology India.2022; 70(6): 2388.     CrossRef
• Genetics of Progressive Supranuclear Palsy: A Review
  Yafei Wen, Yafang Zhou, Bin Jiao, Lu Shen
  Journal of Parkinson's Disease.2021; 11(1): 93.     CrossRef
• Disease course and treatment patterns in progressive supranuclear palsy: A real-world study
  John C. Morgan, Xiaolan Ye, Jennifer A. Mellor, Keisha J. Golden, Jorge Zamudio, Louis A. Chiodo, Yanjun Bao, Tao Xie
  Journal of the Neurological Sciences.2021; 421: 117293.     CrossRef
• Central nystagmus in progressive supranuclear palsy: A neglected clinical feature?
  Maja Klarendic, Manja Hribar, Nina Bozanic Urbancic, Nina Zupancic, Milica G. Kramberger, Maja Trost, Saba Battelino, Diego Kaski, Maja Kojovic
  Parkinsonism & Related Disorders.2021; 84: 15.     CrossRef
• Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial
  Günter U Höglinger, Irene Litvan, Nuno Mendonca, Deli Wang, Hui Zheng, Beatrice Rendenbach-Mueller, Hoi-Kei Lon, Ziyi Jin, Nahome Fisseha, Kumar Budur, Michael Gold, Davis Ryman, Hana Florian, Anwar Ahmed, Ikuko Aiba, Alberto Albanese, Kelly Bertram, Yvet
  The Lancet Neurology.2021; 20(3): 182.     CrossRef
• A Study on the Essential and Parkinson’s Arm Tremor Classification
  Vasileios Skaramagkas, George Andrikopoulos, Zinovia Kefalopoulou, Panagiotis Polychronopoulos
  Signals.2021; 2(2): 201.     CrossRef
• Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors
  Michelle Oyeka, Terngu Ibilah, Jacob Israel, Jose Gavito-Higuera, Ricardo Salazar
  Cureus.2021;[Epub]     CrossRef
• Progressive supranuclear palsy
  N.V. Fedorova, E.V. Bril, T.K. Kulua, A.D. Mikhaylova
  Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2021; 121(5): 111.     CrossRef
• Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care
  Brent Bluett, Alexander Y. Pantelyat, Irene Litvan, Farwa Ali, Diana Apetauerova, Danny Bega, Lisa Bloom, James Bower, Adam L. Boxer, Marian L. Dale, Rohit Dhall, Antoine Duquette, Hubert H. Fernandez, Jori E. Fleisher, Murray Grossman, Michael Howell, Di
  Frontiers in Neurology.2021;[Epub]     CrossRef
• The Genetic Landscape of Parkinsonism-Related Dystonias and Atypical Parkinsonism-Related Syndromes
  Monica Diez-Fairen, Pilar Alvarez Jerez, Joos Berghausen, Sara Bandres-Ciga
  International Journal of Molecular Sciences.2021; 22(15): 8100.     CrossRef
• MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology
  Chihiro Sato, Nipun Mallipeddi, Nupur Ghoshal, Brenton A. Wright, Gregory S. Day, Albert A. Davis, Albert H. Kim, Gregory J. Zipfel, Randall J. Bateman, Audrey Gabelle, Nicolas R. Barthélemy
  Annals of Clinical and Translational Neurology.2021; 8(9): 1817.     CrossRef
• “Parkinson’s disease” on the way to progressive supranuclear palsy: a review on PSP-parkinsonism
  Ján Necpál, Miroslav Borsek, Bibiána Jeleňová
  Neurological Sciences.2021; 42(12): 4927.     CrossRef
• Estimation and discussion of prognosis in neurologic practice. Communication issues with patient with neurological disease
  E. V. Bril, A. V. Khasina, F. A. Abbasov, O. S. Zimnyakova, N. V. Fedorova
  Medical alphabet.2021; (22): 55.     CrossRef
• The Progressive Supranuclear Palsy: Past and Present Aspects
  Theodore P. Parthimos, Kleopatra H. Schulpis
  Clinical Gerontologist.2020; 43(2): 155.     CrossRef
• Machine Learning Techniques to Identify Dementia
  Nivedita Manohar Mathkunti, Shanta Rangaswamy
  SN Computer Science.2020;[Epub]     CrossRef
• My dad and progressive supranuclear palsy (PSP)
  Heather Angus-Leppan
  Practical Neurology.2020; 20(3): 263.     CrossRef
• Tauopathy and Movement Disorders—Unveiling the Chameleons and Mimics
  Jacky Ganguly, Mandar Jog
  Frontiers in Neurology.2020;[Epub]     CrossRef
• A Home-Based, Music-Cued Movement Program Is Feasible and May Improve Gait in Progressive Supranuclear Palsy
  Joanne E. Wittwer, Margaret Winbolt, Meg E. Morris
  Frontiers in Neurology.2019;[Epub]     CrossRef
• Association of autonomic symptoms with disease progression and survival in progressive supranuclear palsy
  Marcos C B Oliveira, Helen Ling, Andrew J Lees, Janice L Holton, Eduardo De Pablo-Fernandez, Thomas T Warner
  Journal of Neurology, Neurosurgery & Psychiatry.2019; 90(5): 555.     CrossRef
• Revisiting the diagnostic value of Evans’ index: lessons from an unusual case of normal pressure hydrocephalus with Evans’ index less than 0.3
  Jung E. Park, Hyunjin Ju, Kayeong Im, Kyum-Yil Kwon
  Neurological Sciences.2019; 40(12): 2637.     CrossRef
• Progressive supranuclear palsy as differential diagnosis of Parkinson's disease in the elderly
  Ricardo Fernández-Ferreira, Raúl Anwar García-Santos, Mayela Rodríguez-Violante, Coral López-Martínez, Ivonne Karina Becerra-Laparra, María Eugenia Torres-Pérez
  Revista Española de Geriatría y Gerontología.2019; 54(5): 251.     CrossRef
• Neuroinflammation as a Common Feature of Neurodegenerative Disorders
  Leonardo Guzman-Martinez, Ricardo B. Maccioni, Víctor Andrade, Leonardo Patricio Navarrete, María Gabriela Pastor, Nicolas Ramos-Escobar
  Frontiers in Pharmacology.2019;[Epub]     CrossRef
• On the journey to uncover the causes of selective cellular and regional vulnerability in neurodegeneration
  Zane Jaunmuktane, Sebastian Brandner
  Acta Neuropathologica.2019; 138(5): 677.     CrossRef
• Clinical Milestones Preceding the Diagnosis of Multiple System Atrophy and Progressive Supranuclear Palsy: A Retrospective Cohort Study
  Louise Wiblin, Rory Durcan, Brook Galna, Mark Lee, David Burn
  Journal of Movement Disorders.2019; 12(3): 177.     CrossRef
• Prediction of the Clinical Severity of Progressive Supranuclear Palsy by Diffusion Tensor Imaging
  Yao-Liang Chen, Xiang-An Zhao, Shu-Hang Ng, Chin-Song Lu, Yu-Chun Lin, Jur-Shan Cheng, Chih-Chien Tsai, Jiun-Jie Wang
  Journal of Clinical Medicine.2019; 9(1): 40.     CrossRef
• Tauopathy with hippocampal 4‐repeat tau immunoreactive spherical inclusions: a report of three cases
  Gabor G. Kovacs, Linda K. Kwong, Murray Grossman, David J. Irwin, Edward B. Lee, John L. Robinson, Eunran Suh, Vivianna M. Van Deerlin, Virginia M. Lee, John Q. Trojanowski
  Brain Pathology.2018; 28(2): 274.     CrossRef
• A case of spinal anesthesia in a patient with progressive supranuclear palsy
  Momoka Tonan, Moritoki Egi, Nana Furushima, Satoshi Mizobuchi
  JA Clinical Reports.2018;[Epub]     CrossRef
• Is it Useful to Classify PSP and CBD as Different Disorders? Yes
  Helen Ling, Antonella Macerollo
  Movement Disorders Clinical Practice.2018; 5(2): 145.     CrossRef
• Difficulties in the diagnosis of four repeats (4R) tauopathic parkinsonian syndromes
  Piotr Alster, Ewa Krzyżanowska, Dariusz Koziorowski, Stanisław Szlufik, Dorota Różański, Joanna Noskowska, Justyna Mianowicz, Adrian Michno, Leszek Królicki, Andrzej Friedman
  Neurologia i Neurochirurgia Polska.2018; 52(4): 459.     CrossRef
• Neuro-ophthalmology of movement disorders
  Olga Waln, Joseph Jankovic
  Expert Review of Ophthalmology.2018; 13(5): 283.     CrossRef
• Role of Neuroimaging on Differentiation of Parkinson’s Disease and Its Related Diseases
  Toshihide Ogawa, Shinya Fujii, Keita Kuya, Shin-ichiro Kitao, Yuki Shinohara, Mana Ishibashi, Yoshio Tanabe
  Yonago Acta Medica.2018; 61(3): 145.     CrossRef
• Gait disorders in adults and the elderly
  Walter Pirker, Regina Katzenschlager
  Wiener klinische Wochenschrift.2017; 129(3-4): 81.     CrossRef
• Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease
  Steve Vucic, Matthew C. Kiernan
  Neurotherapeutics.2017; 14(1): 91.     CrossRef
• Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches
  Adam L Boxer, Jin-Tai Yu, Lawrence I Golbe, Irene Litvan, Anthony E Lang, Günter U Höglinger
  The Lancet Neurology.2017; 16(7): 552.     CrossRef